FindTrial
Sign In

MelanoScan: Detection of recirculating tumor-associated tissue macrophages and circulating melanoma cells as a tool for monitoring melanoma patients: a pilot studie

MelanoScan: Detection of recirculating tumor-associated tissue macrophages and circulating melanoma cells as a tool for monitoring melanoma patients: a pilot studie

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON25430
Enrollment
100
Registered
2021-08-10
Start date
2021-10-05
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MelanoScan

Interventions

Other intervention

Sponsors

LUMC
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: MelanoScan

Exclusion criteria

Exclusion criteria: MelanoScan

Design outcomes

Primary

MeasureTime frame
MelanoScan—

Secondary

MeasureTime frame
MelanoScan—

Contacts

Public ContactJacques J.M. van Dongen

LUMC

j.j.m.van_dongen@lumc.nl+31 71 5265128

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)